Holen Sie sich die Stockscreener-App
31.42
10.63%
3.02
Handel nachbörslich:
31.42
Schlusskurs vom Vortag:
$28.40
Offen:
$28.23
24-Stunden-Volumen:
673.22K
Relative Volume:
0.87
Marktkapitalisierung:
$1.38B
Einnahmen:
$78.02M
Nettoeinkommen (Verlust:
$-73.37M
KGV:
-23.80
EPS:
-1.32
Netto-Cashflow:
$-62.06M
1W Leistung:
+15.60%
1M Leistung:
+49.76%
6M Leistung:
+101.93%
1J Leistung:
+0.00%
1-Tages-Spanne:
$28.01
$32.11
1-Wochen-Bereich:
$26.22
$32.11
52-Wochen-Spanne:
$8.89
$32.11
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
31.42 | 1.25B | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
How currency fluctuations impact Beta Bionics Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Using economic indicators to assess Beta Bionics Inc. potentialMarket Volume Report & Stock Timing and Entry Methods - newser.com
How institutional buying supports Beta Bionics Inc. stockWeekly Market Summary & Real-Time Price Movement Reports - newser.com
Will Beta Bionics Inc. continue its uptrendStop Loss & Fast Gaining Stock Strategy Reports - newser.com
Regression analysis insights on Beta Bionics Inc. performanceWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
How supply chain issues affect Beta Bionics Inc. stockJuly 2025 Final Week & Risk Adjusted Buy and Sell Alerts - newser.com
Beta Bionics Inc. stock chart pattern explainedJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
Is Beta Bionics Inc. stock positioned for long term growthJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Will Beta Bionics Inc. price bounce be sustainableWeekly Risk Summary & AI Powered Market Trend Analysis - newser.com
Fourteen new option listings on November 12th - MSN
Beta Bionics (BBNX) Price Target Increased by 23.23% to 31.93 - Nasdaq
Visual trend scoring systems applied to Beta Bionics Inc.Stop Loss & Long-Term Growth Stock Strategies - newser.com
Is now a turning point for Beta Bionics Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com
The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep? - Benzinga
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):